Helmholtz Munich

Helmholtz Munich conducts research on environmentally triggered diseases, with a special focus on the origins, treatment, and prevention of diabetes, obesity, allergies, and chronic lung diseases. Around 2,500 employees work to accelerate the transfer of findings from the lab to real-world applications, transforming them into personalized therapies. Through the use of artificial intelligence and bioengineering, Helmholtz Munich also promotes early diagnosis and prevention of diseases.

Research Focus Areas:

• Investigation of environmentally triggered diseases (such as diabetes, obesity, allergies, and chronic lung diseases)
• Artificial intelligence and bioengineering
• Study of environmental, lifestyle, and genetic factors
• Early detection and personalized prevention
• Drug discovery